Current Liabilities
Income Taxes Payable
Pfizer Income Taxes Payable increased by 0.9% to $3.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.8%, from $3.11B to $3.13B. Over 5 years (FY 2020 to FY 2025), Income Taxes Payable shows an upward trend with a 24.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Fluctuations often correlate with changes in profitability and the timing of tax installments.
Detailed definition
Income taxes payable represents the current tax liability owed to government authorities based on taxable income earned...
Peer comparison
Varies based on global tax jurisdictions and the company's effective tax rate.
Metric ID:
income_taxes_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.74B | $4.50B | $1.27B | $3.18B | $3.35B | $3.07B | $1.59B | $1.97B | $2.93B | $1.90B | $2.35B | $3.19B | $2.88B | $2.88B | $2.91B | $3.11B | $3.68B | $3.80B | $3.10B | $3.13B |
| QoQ Change | — | +158.1% | -71.8% | +150.9% | +5.4% | -8.3% | -48.3% | +24.1% | +48.7% | -35.2% | +23.8% | +35.9% | -9.6% | -0.2% | +1.1% | +6.7% | +18.4% | +3.4% | -18.3% | +0.9% |
| YoY Change | — | — | — | — | +92.3% | -31.7% | +25.4% | -38.0% | -12.6% | -38.2% | +48.0% | +62.1% | -1.5% | +51.6% | +23.9% | -2.7% | +27.4% | +32.0% | +6.6% | +0.8% |
Range$1.27B – $4.50B
CAGR+13.1%
Avg YoY Growth+15.3%
Median YoY Growth+15.3%
Income Taxes Payable at Other Companies
Frequently Asked Questions
- What is Pfizer's income taxes payable?
- Pfizer (PFE) reported income taxes payable of $3.13B in Q1 2026.
- How has Pfizer's income taxes payable changed year-over-year?
- Pfizer's income taxes payable increased by 0.8% year-over-year, from $3.11B to $3.13B.
- What is the long-term trend for Pfizer's income taxes payable?
- Over 5 years (2020 to 2025), Pfizer's income taxes payable has grown at a 24.2% compound annual growth rate (CAGR), from $1.05B to $3.10B.
- What does income taxes payable mean?
- Taxes owed to the government that have not yet been paid.